Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview
MG Matera, B Rinaldi, C Belardo… - Expert Review of Clinical …, 2022 - Taylor & Francis
Introduction Long-acting muscarinic receptor antagonist (LAMA)/β2-agonist (LABA)
combinations represent a significant improvement in the treatment of chronic obstructive …
combinations represent a significant improvement in the treatment of chronic obstructive …
[HTML][HTML] Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort …
Background Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) exert
a substantial burden on patients and healthcare systems; however, data related to the …
a substantial burden on patients and healthcare systems; however, data related to the …